Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers
暂无分享,去创建一个
Olaf Johan Hartmann-Johnsen | P. Schrotz-King | C. Ulrich | A. Schneeweiss | H. Brenner | A. Broeks | E. Balslev | L. Jansen | M. Sant | M. Jensen | J. Frisell | U. Johansson | A. Voogd | P. Baili | R. Agresti | P. Bourgeois | M. Moreau | T. Tvedskov | M. Kásler | J. Heil | Z. Mátrai | Á. Sávolt | J. Nogaret | A. Gondos | I. Fredriksson | T. van de Velde | P. Nagy
[1] H. Kuerer,et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). , 2015, Annals of surgery.
[2] A. Waldmann,et al. Guideline Conformity Treatment in Young Women with Early-Onset Breast Cancer in Germany , 2014, Breast Care.
[3] M. Piccart,et al. Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] A. D. de Craen,et al. Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care. , 2014, Journal of geriatric oncology.
[5] N. Turner,et al. An update on the medical management of breast cancer , 2014, BMJ : British Medical Journal.
[6] K. Sandelin,et al. Arm lymphoedema after axillary surgery in women with invasive breast cancer , 2014, The British journal of surgery.
[7] Thorsten Kühn,et al. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms , 2013, Senologie.
[8] R. Mansel,et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023). , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Barbara L. Smith,et al. Application of ACOSOG Z0011 Criteria Reduces Perioperative Costs , 2013, Annals of Surgical Oncology.
[10] N. Petrelli,et al. Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations. , 2012, Surgical oncology.
[11] A. Giuliano,et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.
[12] T. Julian,et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.
[13] G. Gatta,et al. Patterns of care for European colorectal cancer patients diagnosed 1996–1998: A EUROCARE High Resolution Study , 2010, Acta oncologica.
[14] M. Federico,et al. Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. , 2010, European journal of cancer.
[15] H. Kehlet,et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. , 2009, JAMA.
[16] Bjørn Møller,et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. , 2009, European journal of cancer.
[17] L. Holmberg,et al. The completeness of the Swedish Cancer Register – a sample survey for year 1998 , 2009, Acta oncologica.
[18] U. Ringborg. The Stockholm Declaration , 2008, Molecular oncology.
[19] H. Brown. The Stockholm declaration signals a cultural change in Europe's approach to cancer research. An interview with Ulrik Ringborg , 2008 .
[20] P. Christiansen,et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. , 2008, Breast.
[21] H. Mouridsen,et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise , 2008, Acta oncologica.
[22] H. Galatius,et al. Organized nation-wide implementation of sentinel lymph node biopsy in Denmark , 2008, Acta oncologica.
[23] T. Julian,et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.
[24] Mark C Kelley,et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.
[25] R. Gelber,et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Umberto Veronesi,et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.
[27] P B Cerrito,et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] A. Giuliano,et al. Sentinel node biopsy in breast cancer. , 1999, Journal of the American College of Surgeons.
[29] D. Weaver,et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.
[30] H. Mouridsen,et al. Danish Breast Cancer Cooperative Group--DBCG. , 1977, Ugeskrift for laeger.